|
SNX14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.539800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.647900E-02 |
| Normal-vs-Stage2 |
5.778200E-01 |
| Normal-vs-Stage3 |
4.762000E-01 |
| Normal-vs-Stage4 |
6.921600E-01 |
| Stage1-vs-Stage2 |
3.394800E-01 |
| Stage1-vs-Stage3 |
1.470810E-01 |
| Stage1-vs-Stage4 |
8.688100E-02 |
| Stage2-vs-Stage3 |
9.418400E-01 |
| Stage2-vs-Stage4 |
7.908600E-01 |
| Stage3-vs-Stage4 |
7.809000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.274960E-01 |
| Normal-vs-AfricanAmerican |
2.872200E-02 |
| Normal-vs-Asian |
2.736500E-02 |
| Caucasian-vs-AfricanAmerican |
8.582200E-02 |
| Caucasian-vs-Asian |
1.903380E-01 |
| AfricanAmerican-vs-Asian |
5.214400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.550000E-01 |
| Normal-vs-Female |
2.874400E-02 |
| Male-vs-Female |
1.804020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.639300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.616550E-01 |
| Normal-vs-Age(61-80Yrs) |
7.467600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.792200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.341430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.626200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.656000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.354200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.116600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.359400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.196960E-01 |
| Classical-VS-Follicular |
1.004020E-03 |
| Classical-VS-Other |
1.388360E-01 |
| Classical-VS-Normal |
1.759790E-03 |
| Tall-VS-Follicular |
3.640200E-01 |
| Tall-VS-Other |
4.690400E-01 |
| Tall-VS-Normal |
6.524000E-01 |
| Follicular-VS-Other |
8.820200E-01 |
| Follicular-VS-Normal |
5.273200E-01 |
| Other-VS-Normal |
5.483000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.475800E-01 |
| Normal-vs-N1 |
6.805200E-01 |
| N0-vs-N1 |
7.846000E-01 |
|
|
